JiffyStent

Revolutionising the management of acute renal colic and kidney stones

A revolutionary medical device that enables the immediate insertion of a ureteric stent in the Emergency Department using clinician’s smartphone as the screen.

The JiffyStent® avoids the need for hospital admission and a trip to the Operating Theatre and associated general anaesthetic, thereby saving considerable time, resources, and costs.

Supported By

The Challenge

10% of the population will experience excruciating kidney stone pain at some point in their lives

Every year, 0.2% of the population has an episode of kidney stone pain requiring a trip to the Emergency Department. And every year, 600,000 stents are inserted to alleviate kidney stone pain.

Current management of the excruciating pain caused by obstructive kidney stones is unnecessarily costly in terms of prolonged pain, money, and time.

It entails a long and complicated regime of strong opioid pain relief, fasting, waiting for Operating Theatre availability, and the administration of general anaesthetic, all for a procedure that should otherwise take under five minutes.

JiffyStent will revolutionise the management of this condition, entering the market with a simple, safe, and cost-effective solution that will reap significant benefits for patient wellbeing, hospital workflow, and health economics.

Patients receive on-the-spot relief from their pain and can resume normal life quicker, while the pressure on already overburdened hospital systems is significantly reduced.

How it Works

Our Roadmap

2022

IDEATION PHASE
First prototype developed
Q1 2023

ALPHA PROTOTYPE PCT
Submitted
Q2 2023

QUALITATIVE RESEARCH
Urologist interviews conducted
Q3 2023

ALPHA PROTOTYPE COMPLETE
Pre-clinical studies demonstrated >95% efficacy Business case finalised
Q4 2023

ANIMAL STUDIES
Ethics for first human trial submitted
Q1 2024

FIRST FUNDING ROUND
Q2 2024

TGA CONFORMITY ASSESSMENT
Tool Making Process begins
Q3 2024

BETA PROTOTYPE READY FOR PIVOT TRIALS
Q4 2024

TOOLING VALIDATION COMPLETE
Second funding round
2025

ANZ MARKET LAUNCH
US Market Launch

The Team

Headquartered in Melbourne, Australia, JiffyStent comprises a small leadership team and dedicated group of advisors. Our team of experts is committed to helping bring to life a cost-effective medical device that transforms the global care pathway for patients with kidney stone pain.

The advisory group brings a wealth of experience and expertise across fields such as med-tech, urology, manufacturing, medical devices, commercialisation, tooling and manufacture, funding, regulation, clinical trials, hospital systems, and procurement.

How it Works

Dr Joseph Ischia, CEO and co founder of JiffyStent

Co-Founder & Chief Executive Officer
Joseph is a urologist, surgeon scientist and clinical entrepreneur with a PhD and Associate Professorship with the University of Melbourne. He has over 15 years experience in the management of acute renal colic and kidneys stones.
Joseph has been the PI and SI on multiple phase 1, 2 and 3 national and international clinical trials. He founded the “Talking Urology” podcast in 2016, one of the top ranking global urology podcasts.

Co-Founder & Chief Engineer
Donald (Don) boasts six decades of engineering experience, including 20+ years dedicated to medical research and the development of medical devices.
In 2006, Don was named among the Top 100 Australia’s most influential engineers.

Chief Operations Officer
Cyril has held senior management and executive roles in the healthcare and not-for-profit sectors, overseeing large-scale global projects.
Cyril is the former global director of clinical services at the Movember Foundation and chief – support services at Ovarian Cancer Australia.